Basic Information
RNALocate ID: | RLID:11003877 |
RNA Symbol: | hsa-miR-26a-2-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-26a-2-3p |
RNA ID: | miRBase:MIMAT0004681 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11003878 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID-D:11000196 | Exosome | Breast milk | |
RLID-D:11000657 | Microvesicle | Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-26a-2-3p | Colorectal adenoma | MNDR-E-MI-33031 |
MNDR | hsa-miR-26a-2-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-33032 |
MNDR | hsa-miR-26a-2-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-33033 |
MNDR | hsa-miR-26a-2-3p | B cell acute lymphoblastic leukemia | MNDR-E-MI-33034 |
MNDR | hsa-miR-26a-2-3p | Gastric cancer | MNDR-E-MI-33035 |
MNDR | hsa-miR-26a-2-3p | Alzheimer disease | MNDR-E-MI-33036 |
MNDR | hsa-miR-26a-2-3p | Head and neck cancer | MNDR-E-MI-33037 |
MNDR | hsa-miR-26a-2-3p | Leukemia | MNDR-E-MI-33038 |
MNDR | hsa-miR-26a-2-3p | Lung cancer | MNDR-E-MI-33039 |
MNDR | hsa-miR-26a-2-3p | Parkinson disease | MNDR-E-MI-33040 |
MNDR | hsa-miR-26a-2-3p | Colonic adenomas | MNDR-E-MI-33041 |
MNDR | hsa-miR-26a-2-3p | Breast cancer | MNDR-E-MI-33042 |
MNDR | hsa-miR-26a-2-3p | Nephroblastoma | MNDR-E-MI-33043 |
MNDR | hsa-miR-26a-2-3p | Colon cancer | MNDR-E-MI-33044 |
MNDR | hsa-miR-26a-2-3p | Colon adenocarcinoma | MNDR-E-MI-33045 |
MNDR | hsa-miR-26a-2-3p | Familial ovarian cancer | MNDR-E-MI-33046 |
MNDR | hsa-miR-26a-2-3p | Glioblastoma | MNDR-E-MI-33047 |
MNDR | hsa-miR-26a-2-3p | Malignant glioma | MNDR-E-MI-33048 |
MNDR | hsa-miR-26a-2-3p | Gastric adenocarcinoma | MNDR-E-MI-33049 |
MNDR | hsa-miR-26a-2-3p | Lung squamous cell carcinoma | MNDR-E-MI-33050 |
MNDR | hsa-miR-26a-2-3p | Lung adenocarcinoma | MNDR-E-MI-33051 |
MNDR | hsa-miR-26a-2-3p | Thyroid carcinoma | MNDR-E-MI-33052 |
MNDR | hsa-miR-26a-2-3p | Bladder urothelial carcinoma | MNDR-E-MI-33053 |
MNDR | hsa-miR-26a-2-3p | Pancreatic adenocarcinoma | MNDR-E-MI-33054 |
MNDR | hsa-miR-26a-2-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-33055 |
MNDR | hsa-miR-26a-2-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-33056 |
MNDR | hsa-miR-26a-2-3p | Testicular germ cell cancer | MNDR-E-MI-33057 |
MNDR | hsa-miR-26a-2-3p | T acute lymphoblastic leukemia | MNDR-E-MI-33058 |
MNDR | hsa-miR-26a-2-3p | Acute t cell leukemia | MNDR-E-MI-33059 |
MNDR | hsa-miR-26a-2-3p | Adenoma | MNDR-E-MI-33060 |
MNDR | hsa-miR-26a-2-3p | Hepatocellular carcinoma | MNDR-E-MI-33061 |
MNDR | hsa-miR-26a-2-3p | Familiar ovarian carcinoma | MNDR-E-MI-33062 |
MNDR | hsa-miR-26a-2-3p | Skin cutaneous melanoma | MNDR-E-MI-33063 |
MNDR | hsa-miR-26a-2-3p | Skin melanoma | MNDR-E-MI-33064 |
MNDR | hsa-miR-26a-2-3p | Acute myelocytic leukemia | MNDR-E-MI-33065 |
MNDR | hsa-miR-26a-2-3p | Colorectal cancer | MNDR-E-MI-33066 |
MNDR | hsa-miR-26a-2-3p | Nasopharynx carcinoma | MNDR-E-MI-33067 |
MNDR | hsa-miR-26a-2-3p | Multiple myeloma | MNDR-E-MI-33068 |
MNDR | hsa-miR-26a-2-3p | Nasopharyngeal cancer | MNDR-E-MI-33069 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | IL10 | Homo sapiens | RR00746234 |
TOP